Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
2.090
+0.110 (5.56%)
Nov 20, 2024, 4:00 PM EST - Market closed

Armata Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-41.36-69.05-36.92-23.16-22.18-19.48
Upgrade
Depreciation & Amortization
1.240.970.891.171.111.35
Upgrade
Loss (Gain) From Sale of Assets
0.080.08---0.66
Upgrade
Stock-Based Compensation
2.730.943.112.883.484.27
Upgrade
Other Operating Activities
2.3129.28--1.250.2-0.2
Upgrade
Change in Accounts Payable
0.040.043.670.180.54-1.37
Upgrade
Change in Other Net Operating Assets
-2.77-9.69-3.23-3.41-1.42-0.82
Upgrade
Operating Cash Flow
-37.73-47.42-32.48-23.58-18.27-15.58
Upgrade
Capital Expenditures
-4.36-8.14-2.21-1.3-0.82-0.22
Upgrade
Sale of Property, Plant & Equipment
0.010.01---0.09
Upgrade
Cash Acquisitions
-----3.01
Upgrade
Investing Cash Flow
-4.35-8.13-2.21-1.3-0.822.88
Upgrade
Short-Term Debt Issued
----0.72-
Upgrade
Long-Term Debt Issued
-54.03----
Upgrade
Total Debt Issued
34.8954.03--0.72-
Upgrade
Net Debt Issued (Repaid)
34.8954.03--0.72-
Upgrade
Issuance of Common Stock
0.130.0144.5226.9323.069.98
Upgrade
Repurchase of Common Stock
-0.1-0.04----
Upgrade
Other Financing Activities
---0.5-1.41-0.57-1
Upgrade
Financing Cash Flow
34.9253.9944.0225.5223.218.98
Upgrade
Net Cash Flow
-7.16-1.579.320.644.12-3.73
Upgrade
Free Cash Flow
-42.09-55.57-34.69-24.88-19.09-15.81
Upgrade
Free Cash Flow Margin
-769.82%-1226.92%-629.85%-556.08%-2320.05%-
Upgrade
Free Cash Flow Per Share
-1.16-1.54-1.01-1.03-1.16-1.97
Upgrade
Levered Free Cash Flow
-23.93-27.75-24.24-16.82-9.83-4.81
Upgrade
Unlevered Free Cash Flow
-18.36-26.11-24.24-16.78-9.44-4.23
Upgrade
Change in Net Working Capital
-9.74-5.692.934.64-0.29-1.61
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.